Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Actinogen recovers some hope from Xanamem wreckage
Health & Biotech
When is the right time for a biotech to try and woo big pharma?
Health & Biotech
Health: Tech giant IBM integrates Total Brain’s mental health tech to help vets
Health & Biotech
Biotron to host international HIV experts after deep-diving into its data
Health & Biotech
Biotech bosses vs investors: are you misunderstanding or are they bad at explaining?
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
Health & Biotech
8 biotechs that either flew or sunk on clinical trial results in 2018
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
News
Lunchtime ASX small cap wrap: who’s waking up with a Monday morning hangover
Director Trades
Director Trades: Who was buying and selling big last week?
News
It’s hard to pick a winner right now, but these 6 small caps are up 150pc since October
Health & Biotech
Check up: here’s what’s happening with 140 ASX small cap health stocks
Health & Biotech
Suda strikes a deal to develop migraine drug in US; shares jump 80pc
Director Trades
Director Trades: Who’s selling down and who’s bidding up?
Health & Biotech
The ASX had questions for Biotron about that big HIV announcement
News
Lunchtime ASX small cap wrap: who’s on a roll today
Director Trades